International Biotechnology Trust PLC Relmada Therapeutics, Inc. Call Options Transaction History
International Biotechnology Trust PLC
- $295 Million
- Q3 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RLMD
# of Institutions
55Shares Held
5.43MCall Options Held
0Put Options Held
0-
Driehaus Capital Management LLC Chicago, IL740KShares$1.58 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA619KShares$1.32 Million0.0% of portfolio
-
Black Rock Inc. New York, NY573KShares$1.22 Million0.0% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD397KShares$844,5740.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA364KShares$775,4840.0% of portfolio
About RELMADA THERAPEUTICS, INC.
- Ticker RLMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,608,500
- Market Cap $60.9M
- Description
- Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...